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ABSTRACT
Background We examined associations between different chronic morbidities and help-seeking for possible cancer symptoms.
Methods Postal survey of individuals aged >50 years in England. Participants could report prior morbidities in respect of 12 pre-deﬁned
conditions. Among patients experiencing possible cancer symptoms we examined associations between speciﬁc morbidities and self-reported
help-seeking (i.e. contacted versus not contacted a GP) for each alarm symptom using regression analyses.
Results Among 2042 respondents (42% response rate), 936 (46%) recently experienced 1 of 14 possible cancer symptoms considered in our
analysis. Of them, 80% reported one or more morbidities, most frequently hypertension/hypercholesterolemia (40%), osteomuscular (36%) and
heart diseases (21%). After adjustment for socio-demographic characteristics, patients with hypertension/hypercholesterolemia were more likely
to report help-seeking for possible cancer symptoms, such as unexplained cough (OR = 2.0; 95% conﬁdence interval (CI) 1.1–3.5), pain (OR =
2.2; 95% CI 1.0–4.5) and abdominal bloating (OR = 2.3; 95% CI 1.1–4.8). Urinary morbidity was associated with increased help-seeking for
abdominal bloating (OR = 5.4; 95% CI 1.2–23.7) or rectal bleeding (OR = 5.8; 95% CI 1.4–23.8). In contrast, heart problems reduced help-
seeking for change in bowel habits (OR = 0.4; 95% CI 0.2–1.0).
Conclusions Comorbidities are common and may facilitate help-seeking for possible cancer symptoms, but associations vary for speciﬁc
symptom-comorbidity pairs. The ﬁndings can contribute to the design of future cancer symptom awareness campaigns.
Keywords cancer, comorbidity, diagnosis, help-seeking, symptoms
Introduction
Chronic conditions affect large proportions of older indivi-
duals. Data from both Scotland and England indicate that
about half of the general population have a long-standing
health condition, of whom half have two or more morbid-
ities.1,2 As older age is associated with both a higher preva-
lence of chronic diseases and higher cancer risk, it is
important to examine the likely inﬂuence of pre-existing
morbidities (hereafter called comorbidities) on help-seeking
behavior for new symptoms that may relate to cancer. Given
the high morbidity prevalence, even small effects can have
important consequences at population level.
Although some studies indicate that comorbidities may
lead to more prompt help-seeking in patients with upper3–5
and lower gastrointestinal cancers6 and no delay for lung
cancer symptoms7,8; other studies suggest that comorbidities
can delay as well as facilitate help-seeking, with various factors
possibly coming into play, including the type of comorbidity
and symptom characteristics (e.g. evolution of symptoms over
time or their severity).9,10 Mechanisms underlying the possible
association between comorbidity and help-seeking have only
been partially explored. Comorbidities may enable the report-
ing of possible cancer symptoms during healthcare encounters
for the chronic problem. Sometimes patients might feel that
help-seeking for vague symptoms is only appropriate if the
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consultation is also needed for a co-existing morbidity.11
Familiarity with the healthcare provider and/or system may
also facilitate prompt help-seeking. Such mechanisms are sup-
ported by patients’ accounts in qualitative interviews12 and are
in line with higher consultation rates among patients with
chronic health problems .13
On the other hand, comorbidities may lead to delays by
interfering with symptom appraisal and/or help-seeking if the
management of the chronic disease(s) is perceived as more
important than the new symptom, particularly if the new
symptoms are vague and do not interfere with daily life.10
Similarly, patients (and their carers) may attribute new symp-
toms to pre-existing disease(s), delaying help-seeking or delay-
ing reporting of potential cancer symptoms.12,14–16
Complex interactions between speciﬁc types of morbidity
and the nature of the potential cancer symptoms are likely.
For example, some lung cancer patients reported pre-
existing respiratory and cardiac comorbidities as reasons for
delayed help-seeking,9,14 but others were able to identify the
‘unusual or changing symptoms’ despite chronic respiratory
problems.9
Despite these complex mechanisms and possible interac-
tions between different types of comorbidities and symptom
characteristics, the majority of population-based studies have
only reported on the overall effect of comorbidity, with only
a few studies examining speciﬁc comorbidities.
Against this background, our objective was to evaluate
the associations between speciﬁc comorbidities and help-
seeking for different cancer alarm symptoms among a popu-
lation sample. Our broader aim was to produce evidence
that can contribute to the design of future public health edu-
cational interventions (e.g. ‘awareness campaigns’) for improv-
ing early diagnosis of cancer.
Methods
A health survey was mailed in October 2013 to 4913 indivi-
duals aged ≥50 years in England from four general practices
and 2042 questionnaires were returned (response rate 42%).
Details of the study methods have been previously
described.17,18 Exclusion criteria were a previous cancer
diagnosis and severe physical or mental health problems
based on primary care records. Participants were asked to
report if they experienced any of 14 ‘alarm’ symptoms for
possible cancer in the last 3 months. The symptom list was
based on the Cancer Awareness Measure19 and Be Clear on
Cancer Campaigns.20
Participants were asked whether they had contacted their GP
for each of the symptoms experienced during the last 3 months
and the time between symptom onset and help-seeking. For the
present study, we dichotomized help-seeking, with our pri-
mary help-seeking outcome being deﬁned as having contacted
the GP for the experienced symptom (independently of the
time interval between symptom onset and help-seeking) ver-
sus not having contacted the GP (see Box 1). As information
on help-seeking was reported separately for each recently
Box 1 Survey questions
(1) In the last 3 months, have you had the following…? (indicate yes/no for each of the following) Response categories (14):
Unexplained weight loss, unexplained lump, change in the appearance of a mole or a new mole, persistent change in bowel
habits, blood in urine, persistent change in bladder habits, any breast changes, persistent unexplained pain, persistent difﬁculty
swallowing, persistent cough or hoarseness, rectal bleeding (i.e. bleeding from the back passage or blood in the bowel motions),
other unexplained bleeding, abdominal bloating (i.e. bloating of your tummy or belly), a sore that does not heal.
(2) Approximately how long after the symptom began did you contact the GP about it? Response categories: a) Did not
contact the GP, b) Not contacted the GP yet but plan to, c) within 1–2 weeks of noticing the symptom, d) within 1 month of
noticing the symptom, e) within 6 weeks of noticing the symptom, f) within 3 months of noticing the symptom, g) after >3
months of noticing the symptom. [Our primary outcome included response categories a–b denoting no help-seeking versus
response categories c–g denoting help-seeking. For our secondary outcome, i.e. prompt help-seeking (within 3 months from
symptom onset), response categories c–f were treated as denoting prompt help-seeking versus response categories a, b and g as
denoting non-prompt help-seeking].
(3) Do you have a diagnosis of any of the following conditions/illnesses? Response categories (1): arthritis, cancer, circulation
problems, chest problems, cholesterol problems, depression, diabetes, heart problems, high blood pressure, kidney problems,
stroke, other (please specify-in free-text). The above pre-coded and free-text responses were further aggreagated into 10 new
morbidity categories in order to have sufﬁcient numbers per category for further analyses, comprising: hypertension/
hypercholesterolemia, osteomuscular, respiratory, heart problems, mental health (depression and other free-text mental health
problems), diabetes/endocrinological, neurological, urinary, gastrointestinal problems and others (free-text responses such as skin,
eye and hearing problems).
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experienced symptom, all analyses were stratiﬁed by symptom
category (i.e. 14 different strata). In addition, we dichoto-
mized the speed of help-seeking into ‘sought help within 3
months from symptom onset’ versus ‘did not seek help
for 3 or more months from symptom onset’. Prompt
help-seeking (within 3 months from symptom onset) ver-
sus non-prompt help-seeking was examined as a secondary
outcome.
Information on comorbidities was based on respondents’
replies to the question ‘Do you have a diagnosis of any of
the following conditions/illnesses?’ (Tick all that apply/if
other, please specify). This encompassed 12 pre-coded mor-
bidity categories including a free-text response option for
adding any other morbidity (see Box 1). Using the struc-
tured and free-text responses we deﬁned ten morbidity cat-
egories that were included in further analyses: hypertension/
hypercholesterolemia, osteomuscular, respiratory, heart, mental
health, diabetes/endocrinological, neurological, urinary, gastro-
intestinal problems and others.
Analysis
We examined the most frequent single, dual and triple symp-
tom and comorbidity combinations. Because of sample size
limitations, further analyses were restricted to the seven
most frequent symptoms (n > 100), i.e. persistent cough or
hoarseness, persistent unexplained pain, abdominal bloating,
change in the appearance of mole, persistent change in
bowel habits, persistent change in bladder habits and rectal
bleeding.
Within each symptom stratum, we examined univariable
associations between each speciﬁc comorbidity and help-seeking
for the speciﬁc symptom and socio-demographic factor (age,
sex and educational level). Smoking status was also included in
univariable analysis among respondents with a cough. Subse-
quently, we performed multivariable logistic regression examin-
ing the association between speciﬁc comorbidities and help-
seeking, controlling for socio-demographic characteristics. A
separate model was used for each cancer alarm symptom. Each
ﬁnal model included variables thought a priori to be potentially
associated with help-seeking (sex, age and educational level) and
those comorbidities associated with help-seeking in univariable
analysis at P-value <0.2. All analyses were performed for our
main outcome of interest (help-seeking versus non help-seeking)
and subsequently repeated for our secondary outcome (prompt
versus non-prompt help-seeking).
In order to limit the possibility of reverse causation bias,
we restricted our analyses a priori to comorbidity-symptom
pairs with non-overlapping clinical presentations, such as
chronic conditions affecting body systems or organs unrelated
to the speciﬁc symptom/sign (e.g. pre-existing chronic obstruct-
ive pulmonary disease (COPD) and change in the appearance
of a skin mole) or asymptomatic comorbidities (e.g. hyperten-
sion or hypercholesterolemia). Consequently, we excluded
from our analyses morbidity-symptom pairs such as COPD
and cough or osteomuscular problems and pain.
STATA 14 was used for statistical analyses and the signiﬁ-
cance level was set at P < 0.05.
Results
Out of 2042 respondents 936 (46%) had experienced at least
one cancer alarm symptom during the last 3 months. After
excluding 21 individuals who reported a previous cancer
diagnosis in the free-text responses, 915 symptomatic parti-
cipants were available for analysis. Both symptomatic and
asymptomatic participants had a median age of 64 years
(interquartile range (IQR):57–71, and IQR: 57–70, respect-
ively). Symptomatic participants reported a median of one
symptom (IQR: 1–2) and two comorbidities (IQR: 1–3)
whereas asymptomatic participants reported one comorbid-
ity (IQR: 1–2).
Subsequent analyses refer only to symptomatic participants.
The most frequently reported symptoms included persistent
cough or hoarseness (30%; n = 272), persistent unexplained
pain (23%; n = 213), abdominal bloating (23%; n = 210),
change in bowel habits (18%; n = 167) and persistent change
in bladder habits (17%; n = 158). The most frequent
comorbidities were hypertension/hypercholesterolemia (40%;
n = 368), osteomuscular (36%; n = 330) and heart diseases
(21%; n = 189) (Table 1).
Approximately half of symptomatic participants (56%)
reported one symptom, 24% two and 11% three symp-
toms. A single comorbidity was reported by 33% of symp-
tomatic participants, while 25 and 12% reported dual or
triple comorbidities, respectively. The prevalence of each
speciﬁc comorbidity reported either as a single comorbidity
or in combination with other comorbidities is shown in
Table 2. The most frequent dual comorbidity combination
was osteomuscular problems and hypertension/hyperchol-
esterolemia (further details in Appendix). The combination
of osteomuscular, hypertension/hypercholesterolemia and
heart problems was the most frequent triple morbidity
(2%; n = 17).
Help-seeking for possible cancer symptoms—
univariable analysis
Subsequent analyses were stratiﬁed according to the most
frequent symptom categories. The proportion of participants
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having contacted their GP for their symptoms was 62%
for unexplained pain, 54% for change in bowel habits, 48%
for change in bladder habits, 46% for chronic cough, 39%
for changes in a mole and 36% for rectal bleeding.
Similarly prompt help-seeking (within 3 months from
symptom onset) ranged from 48% for unexplained pain to
25% for rectal bleeding. Help-seeking for persistent cough
or unexplained pain was associated with hypertension/
hypercholesterolemia in univariable analysis (Table 3).
Among participants experiencing abdominal bloating help-
seeking was associated with having osteomuscular pro-
blems and hypertension/hypercholesterolemia. For patients
with rectal bleeding help-seeking was associated with urin-
ary comorbidities.
Table 1 Demographic characteristics among symptomatic and asymptomatic participants
Symptomatic (N = 915) n (%) Asymptomatic (N = 1106) n (%)
Sex Males 373 (40.8) 551 (49.8)
Females 534 (58.4) 543 (49.1)
Education Higher education 341 (37.3) 389 (35.2)
Higher education below degree/A level 164 (17.9) 212 (19.2)
ONC/BTCE/O Level/GCSE 143 (15.6) 172 (15.6)
No formal qualiﬁcations 170 (18.6) 251 (22.7)
Other 75 (8.2) 62 (5.6)
Smoking status No, I have never smoked 408 (44.6) 522 (47.2)
Not now, but I used to smoke 378 (41.3) 451 (40.8)
Yes, I smoke occasionally 28 (3.1) 43 (3.9)
Yes, I am a current smoker 96 (10.5) 82 (7.4)
Cancer symptom Persistent cough or hoarseness 272 (29.7)
Persistent unexplained pain 213 (23.3)
Abdominal bloating 210 (23.0)
Change in bowel habits 167 (18.3)
Change in bladder habits 158 (17.3)
Rectal bleeding 145 (15.8)
Change in a mole 144 (15.7)
Unexplained lump 72 (7.9)
Unexplained weight loss 68 (7.4)
A sore that does not heal 55 (6.0)
Blood in urine 48 (5.2)
Persistent difﬁculty swallowing 47 (5.1)
Any breast changes 31 (3.4)
Other bleeding 23 (2.5)
Comorbidity Hypertension/hypercholesterolemia 368 (40.2) 401 (36.3)
Osteomuscular problems 330 (36.1) 232 (21.0)
Heart problems 189 (20.7) 145 (13.1)
Respiratory problems 126 (13.8) 51 (4.6)
Mental health problems 110 (12.0) 58 (5.2)
Diabetes/thyroid 87 (9.5) 86 (7.8)
Neurological problems 69 (7.5) 23 (2.1)
Urinary problems 62 (6.8) 24 (2.2)
Gastrointestinal problems 55 (6.0) 0 (0.0)
Other (a) 63 (6.9) 223 (20.2)
No comorbidity 187 (20.4) 359 (32.5)
Numbers may not add up to the total due missing data for some variables. For symptoms and comorbidity totals exceed 100% due to multiple symptoms
and comorbidities.
(a) Other comorbidity; skin, eye, hearing problems etc.
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Multivariable analyses for the association between
comorbidities and help-seeking for cancer
symptoms
Multivariable logistic regression conﬁrmed most of the pre-
viously described associations between speciﬁc comorbidities
and help-seeking for common cancer ‘alarm’ symptoms,
adjusting for socio-demographic factors and the presence of
multiple morbidities. In particular, hypertension/hyperchol-
esterolemia was associated with a higher likelihood of help-
seeking for patients experiencing cough (OR = 2.0; 95%
conﬁdence interval (CI) 1.1–3.5), persistent pain (OR = 2.2;
95% CI 1.1–4.5) or abdominal bloating (OR = 2.3; 95% CI
1.1–4.8). Urinary problems were associated with increased
help-seeking for patients experiencing abdominal bloating
(OR = 5.4; 95% CI 1.2–23.7) and rectal bleeding (OR = 5.8;
95% CI 1.4–23.8). Heart disease was the only comorbidity
associated with a lower likelihood of help-seeking, speciﬁcally
for patients experiencing change in bowel habits (OR = 0.4;
95% CI 0.2–1.0).
Secondary analyses examining the association between
comorbidity and prompt help-seeking (within 3 months
from symptom onset) versus non-prompt help-seeking con-
ﬁrmed the ﬁndings from our main analysis (secondary ana-
lysis in Appendix).
Discussion
Main ﬁndings of this study
In our population-based sample, the large majority of indivi-
duals who experienced a possible alarm symptom for cancer
had at least one co-existing morbidity, most commonly
hypercholesterolemia/hypertension, osteomuscular or heart
problems. The presence of comorbidity, such as hyperten-
sion/hypercholesterolemia was signiﬁcantly associated with
increased help-seeking for commonly reported alarm symp-
toms, including persistent unexplained cough, unexplained
pain and abdominal bloating, independently of socio-
demographic characteristics. Urinary comorbidities increased
help-seeking among patients with rectal bleeding and
abdominal bloating. In contrast, having a heart comorbidiy
decreased help-seeking for change in bowel habits.
What is already known
Chronic conditions affect signiﬁcant proportions of older
individuals.1,2 Theoretical models acknowledge their poten-
tial effect on help-seeking for cancer symptoms and diagnos-
tic delays.21 However, large studies to date have mainly
evaluated the overall presence/absence and possibly the
number of morbidities,5,6,22,23 with few surveys having eval-
uated speciﬁc types of comorbidities.10,24,25 Moreover, deﬁ-
nitions and data collection methods vary widely between
studies, ranging from summary scores (e.g. Charlson
comorbidity index) based on medical records, to patient self-
reports using open or pre-coded questions. Some qualitative
patient interviews offer detailed information on speciﬁc
comorbidities and their effect on help-seeking,9 but they are
by nature limited to a small number of purposively selected
patients.
Our ﬁndings are in line with prior studies examining fac-
tors inﬂuencing the time interval before cancer diagnosis
among patients with upper3–5 and lower gastrointestinal can-
cers6 and with some patient interview studies showing that
Table 2 Prevalence of each comorbidity as a single comorbidity or in combination with other comorbidities (dual and triple morbidities) among
symptomatic individuals (Total N = 915)
Overall prevalence (as single
or multiple morbidity) (a)
Single morbidity Dual morbidity Triple morbidity Four or more
morbidities
% (n) % (n) % (n) % (n) % (n)
Hypertension/hypercholesterolemia 40.2 (368) 8.7 (80) 14.9 (136) 9.0 (82) 7.6 (70)
Osteomuscular 36.1 (330) 8.5 (78) 12.6 (115) 7.7 (70) 7.3 (67)
Heart 20.7 (189) 2.8 (26) 5.8 (53) 3.3 (30) 8.7 (80)
Respiratory 13.8 (126) 2.6 (24) 3.8 (35) 2.7 (25) 4.6 (42)
Mental Health 12 (110) 1.7 (16) 4.3 (39) 2.2 (20) 3.8 (35)
Diabetes/Thyroid 9.5 (87) 1.2 (11) 2.2 (20) 3.4 (31) 2.7 (25)
Neurological 7.5 (69) 1.3 (12) 1.5 (14) 1.9 (17) 2.8 (26)
Urinary 6.8 (62) 2.1 (19) 1.1 (10) 1.5 (14) 2.1 (19)
Gastrointestinal 6 (55) 2.0 (18) 1.7 (16) 1.0 (9) 1.3 (12)
Other 6.9 (63) 2.3 (21) 2.4 (22) 1.0 (9) 1.2 (11)
(a) The numbers reported in the ﬁrst column re-iterate some of the data reported in Table 1 and are shown here for completeness.
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Table 3 Univariable logistic regression for the association between each speciﬁc comorbidity and help-seeking for possible cancer symptoms
Crude OR of help-seeking (95% CI) P-value
Persistent cough or
hoarseness (n = 235)
Persistent unexplained
pain (n = 184)
Abdominal Bloating
(n = 172)
Change in bowel
habits (n = 142)
Change in bladder
habits (n = 134)
Change in a mole or a
new mole (n = 127)
Rectal bleeding
(n = 117)
Comorbidity
Osteomuscular 1.7 (1.0, 2.9) P = 0.05 (a) 2.1 (1.1, 4.0) P = 0.03 1.4 (0.7, 2.9) P = 0.30 1.5 (0.8, 3.1) P = 0.23 0.6 (0.3, 1.3) P = 0.15 1.8 (0.8, 3.8) P = 0.13
Hypertension/
hypercholesterolemia
2.3 (1.4, 3.9) P = 0.002 2.2 (1.1, 4.2) P = 0.02 2.8 (1.4, 5.4) P < 0.01 1.0 (0.5, 2.0) P = 0.95 1.4 (0.7, 2.8) P = 0.36 1.8 (0.9, 3.7) P = 0.12 1.6 (0.8, 3.5) P = 0.21
Mental health 1.2 (0.5, 2.8) P = 0.7 (a) (a) 1.1 (0.5, 2.6) P = 0.84 1.2 (0.5, 3.0) P = 0.73 0.9 (0.3, 2.8) P = 0.83 1.3 (0.4, 4.4) P = 0.64
Respiratory (a) 0.6 (0.3,1.6) P = 0.32 1.57 (0.6, 3.8) P = 0.32 0.6 (0.2, 1.8) P = 0.38 0.5 (0.2, 1.6) P = 0.25 0.3 (0.1, 1.0) P = 0.06 1.3 (0.4, 4.4) P = 0.64
Heart problems 0.9 (0.5, 1.7) P = 0.78 1.3 (0.6, 3.0) P = 0.56 1.58 (0.8, 3.3) P = 0.21 0.6 (0.3, 1.3) P = 0.18 1.1 (0.5, 2.4) P = 0.80 0.7 (0.3, 2.0) P = 0.54 1.5 (0.7, 3.7) P = 0.33
Diabetes/ Thyroid 1.6 (0.7, 4.0) P = 0.27 1.0 (0.4, 2.8) P = 1.00 (a) 2.4 (0.8, 7.9) P = 0.13 3.2 (0.7, 16.2) P = 0.15 0.5 (0.1, 3.1) P = 0.45 2.1 (0.6, 7.8) P = 0.28
Urinary 1.4 (0.6, 3.4) P = 0.48 4.4 (0.5, 35.5) P = 0.17 5.8 (1.5, 22.6) P = 0.01 1.4 (0.5, 4.4) P = 0.52 (a) 0.4 (0.1, 2.1) P = 0.25 4.5 (1.2, 17.6) P = 0.03
Neurological 1.3 (0.5, 3.2) P = 0.63 (a) (a) (a) (a) 1.4 (0.4, 4.9) P = 0.63 1.0 (0.2, 4.5) P = 0.97
Gastrointestinal 0.4 (0.1, 1.7) P = 0.21 0.5 (0.2, 1.4) P = 0.19 2.1 (0.9, 5.2) P = 0.10 (a) 0.6 (0.1, 2.9) P = 0.56 1.6 (0.3, 8.8) P = 0.62 (a)
Bold represents associations at P < 0.05.
(a) Excluded pairs where symptoms might be due to the morbidity (e.g. ‘COPD-cough; osteomuscular-pain’).
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comorbidities can facilitate help-seeking or encourage
reporting of possible cancer symptoms during medical
encounters.9 Similarly, a study on emergency colorectal can-
cer diagnosis showed a higher prevalence of hypertension in
non-emergency patients, suggesting that regular GP visits
for blood pressure monitoring might have prevented a
delayed cancer diagnosis.25 However, the overall evidence is
mixed, with some other studies reporting no association
between speciﬁc comorbidities (diabetes, heart and respira-
tory problems) and emergency colon cancer diagnosis26 or
advanced stage at diagnosis.23
On the other hand, severe morbidities, such dementia,
cerebrovascular disease, congestive heart failure and liver
disease have been reported to be strongly associated with
emergency colorectal cancer diagnosis.27 Cardiac and
respiratory diseases have also been reported as reasons for
delayed help-seeking among lung cancer patients.9,14 In
some cases, comorbidities may lead to delays by interfering
with symptom appraisal if the cancer symptom is attributed
to the pre-existing condition.12,14–16
Therefore, prior evidence indicates that comorbidities
may have complex effects, possibly acting both as barriers
and as facilitators, depending on the speciﬁc type of morbid-
ity and cancer symptom characteristics.
What this study adds
Our study substantially ampliﬁes the existing literature provid-
ing detailed information on the associations between speciﬁc
comorbidity types and different cancer symptoms. A particular
strength of our study is the inclusion of information on help-
seeking for a range of common ‘alarm’ symptoms in the con-
text of ten different comorbid conditions in a relatively large
population-based sample. Having been able to examine spe-
ciﬁc comorbidity-cancer symptom pairs has allowed to appro-
priately characterize heterogeneity in the associations, with
some comorbidities acting as barriers and others as facilitators.
Concordant with prior evidence,3–6,9 we found that osteo-
muscular morbidities and hypertension/hypercholesterol-
emia, which often require regular GP visits (for pain
management or monitoring of blood pressure) facilitate
help-seeking possibly by offering opportunities for discuss-
ing potential cancer symptoms in the context of ‘routine’
clinical encounters related to chronic disease management
and monitoring. On the other hand, morbidities that are per-
ceived as particularly serious and requiring more urgent atten-
tion, such as cardiac problems, seem to delay help-seeking in
our study, as they might have led patients to postpone the dis-
cussion of other symptoms particularly if symptoms are vague
or not interfering with daily life.
Our ﬁndings suggest that public health educational inter-
ventions for improving awareness of cancer symptoms and
diagnose cancer earlier should take into account that indivi-
duals experiencing cancer symptoms often also have
comorbidities, which affect symptom appraisal and help-
seeking. Patients with comorbidities requiring regular GP
visits (e.g. hypertension) might particularly beneﬁt from hol-
istic clinical management28 with clear guidance and encour-
aging them to report new symptoms when those occur.
Given the high prevalence of co-existing morbidity among
patients with potential cancer symptoms further studies are
needed to exactly understand how to improve early cancer
diagnosis among comorbid patients.
Limitations
Due to the cross-sectional study design and due to the fact
that information on symptoms and comorbidity was self-
reported we cannot exclude reverse causation between help-
seeking and comorbidity, i.e. participants who sought help
for symptoms might have been more likely to have received
(or reported) a comorbidity diagnosis. However, we have
limited this possible bias by only including in the analysis
only comorbidity-symptom pairs that are unrelated physiolo-
gically or that affect different organs/systems and asymp-
tomatic comorbidities. Longitudinal studies would be
necessary to overcome this possible limitation. Severity of
symptoms and comorbidity might also inﬂuence help-
seeking, but this information was not available in our study.
It should also be noted that comorbidities may affect not
only patients’ initial decisions to seek help for cancer symp-
toms, but they might also complicate the subsequent diag-
nostic process, inﬂuencing both patients and the healthcare
providers during the different diagnostic phases. Signiﬁcant
event audits28 and patient interviews9 have shown that
chronic morbidities might lead to missed opportunities to
investigate symptoms suggestive of cancer or to patients
delaying returning to the doctor after their symptoms were
initially attributed to a co-existing morbidity.12,14 These fac-
tors were not examined in the present study and further
research is warranted.
Conclusions
Understanding the effect of co-existing morbidities on help-
seeking in case of potential cancer symptoms is important,
given that the vast majority of older individuals who experi-
ence an alarm symptom have chronic health problems. We
reported how individuals with different morbidities may gen-
erally be more likely to seek help for common alarm
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symptoms compared to individuals without morbidity.
These ﬁndings may be one of the many manifestations of
‘paradoxical beneﬁts’ of morbidity. However, we have also
shown that the effect might vary for speciﬁc symptom-
comorbidity pairs and speciﬁc attention needs to be dedi-
cated to some comorbidities, which might delay help-
seeking. Interventions for improving early cancer diagnosis
should take into account that most patients at risk of devel-
oping cancer will have at least one pre-existing morbidity
with heterogeneous effects of common morbidities on help-
seeking.
Larger quantitative studies are needed focusing on the
effect of speciﬁc morbidities on help-seeking for different
alarm symptoms and examining the inﬂuence of morbidity
on doctors’ decision-making.
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Appendix
Appendix 1 Most frequent comorbidity combinations among individuals with dual comorbidity (percentages are calculated on the total number of
individuals with dual comorbidity (N = 230))
Hypertension/
hypercholesterolemia
Osteomuscular Heart Respiratory Mental
health
Diabetes/
thyroid
Neurological Urinary Gastrointestinal Other
Hypertension/
hypercholesterolemia
— 23.9 (55) 10.4 (24) 6.1 (14) 3.5 (8) 3.9 (9) 3.5 (8) 2.2 (5) 1.7 (4) 3.9 (9)
Osteomuscular — 5.2 (12) 5.2 (12) 7.4 (17) 2.6 (6) 0.9 (2) 0.9 (2) 1.3 (3) 2.6 (6)
Heart — 2.2 (5) 2.2 (5) 1.3 (3) 1.3 (3) 0.0 (0) 0.4 (1) 0.0 (0)
Respiratory — 0.0 (0) 0.4 (1) 0.0 (0) 0.9 (2) 0.0 (0) 0.4 (1)
Mental Health — 0.4 (1) 0.0 (0) 0.4 (1) 1.7 (4) 1.3 (3)
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Appendix 2 Secondary analysis examining the association between morbidity and prompt help-seeking (within 3 months from symptom onset) versus non-prompt help-seeking—Univariable analysis
Crude OR of prompt help-seeking (95% CI) P-value
Persistent cough or
hoarseness (n = 235)
Persistent unexplained
pain (n = 184)
Abdominal Bloating
(n = 172)
Change in bowel
habits (n = 142)
Change in bladder
habits (n = 134)
Change in a mole or a
new mole (n = 127)
Rectal bleeding
(n = 117)
Comorbidity
Osteomuscular 1.4 (0.8, 2.4) P = 0.19 (a) 1.8 (0.9, 3.6) P = 0.10 1.1 (0.5, 2.1) P = 0.87 1.0 (0.5, 2.0) P = 0.98 0.8 (0.4, 1.8) P = 0.65 1.2 (0.5, 2.6) P = 0.73
Hypertension/
hypercholesterolemia
2.3 (1.3, 3.9) P = 0.003 1.8 (1.0, 3.2) P = 0.06 2.4 (1.2, 4.8) P = 0.02 0.7 (0.4, 1.4) P = 0.34 1.1 (0.5, 2.2) P = 0.83 2.3 (1.1, 4.7) P = 0.03 1.6 (0.7,3.6) P = 0.25
Mental health 1.1 (0.5, 2.6) P = 0.79 (a) (a) 0.5 (0.2, 1.1) P = 0.09 1.0 (0.4, 2.6) P = 1.00 0.9 (0.3, 2.9) P = 0.85 0.4 (0.1, 2.0) P = 0.28
Respiratory (a) 0.6 (0.2,1.4) P = 0.22 1.1 (0.4, 2.9) P = 0.89 0.7 (0.2, 2.1) P = 0.51 0.7 (0.2, 2.4) P = 0.57 0.5 (0.1,1.6) P = 0.24 1.1 (0.3, 4.1) P = 0.84
Heart problems 0.8 (0.4, 1.6) P = 0.61 1.2 (0.6, 2.6) P = 0.58 1.0 (0.4, 2.3) P = 1.00 0.7 (0.3, 1.4) P = 0.30 1.0 (0.5, 2.3) P = 0.91 0.5 (0.2, 1.5) P = 0.23 1.8 (0.7, 4.4) P = 0.20
Diabetes/ Thyroid 1.2 (0.5, 2.9) P = 0.66 1.2 (0.5, 3.2) P = 0.67 (a) 1.3 (0.5, 3.5) P = 0.61 3.6 (0.8, 14.9) P = 0.08 1.0 (0.2, 6.0) P = 0.97 3.9 (1.0, 14.6) P = 0.05
Urinary 0.8 (0.3, 2.0) P = 0.57 1.3 (0.4, 4.9) P = 0.66 1.8 (0.5, 6.4) P = 0.37 1.0 (0.3, 2.8) P = 0.96 (a) 0.7 (0.1, 4.0) P = 0.70 5.5 (1.5, 19.7) P = 0.01
Neurological 2.0 (0.8, 5.1) P = 0.14 (a) (a) (a) (a) 0.5 (0.1, 2.0) P = 0.34 0.9 (0.17, 4.84) P = 0.90
Gastrointestinal 0.4 (0.1, 1.8) P = 0.22 0.8 (0.3, 2.2) P = 0.59 1.5 (0.6, 3.9) P = 0.43 (a) 1.2 (0.3, 5.8) P = 0.79 3.0 (0.5,17.3) P = 0.21 (a)
Bold represents associations at P < 0.05.
(a) Excluded pairs where symptoms might relate to morbidity (e.g. ‘COPD-cough; osteomuscular-pain’).
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